These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9227291)

  • 1. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.
    Hamon M; Amant C; Bauters C; Richard F; Helbecque N; McFadden E; Lablanche JM; Bertrand M; Amouyel P
    Heart; 1997 Jun; 77(6):502-5. PubMed ID: 9227291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease.
    Gruchala M; Ciećwierz D; Ochman K; Wasag B; Koprowski A; Wojtowicz A; Dubaniewicz W; Targoński R; Sobiczewski W; Grzybowski A; Romanowski P; Limon J; Rynkiewicz A
    Clin Chem Lab Med; 2003 Apr; 41(4):522-8. PubMed ID: 12747597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease.
    Alvarez R; Reguero JR; Batalla A; Iglesias-Cubero G; Cortina A; Alvarez V; Coto E
    Cardiovasc Res; 1998 Nov; 40(2):375-9. PubMed ID: 9893731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease.
    Nakauchi Y; Suehiro T; Yamamoto M; Yasuoka N; Arii K; Kumon Y; Hamashige N; Hashimoto K
    Atherosclerosis; 1996 Sep; 125(2):161-9. PubMed ID: 8842348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allelic variants of genes: angiotensin I-converting enzyme (ACE), angiotensin-II type 1 receptor (AT1R), methylenetetrahydrofolate reductase and left ventricular mass in patients with myocardial infarction].
    Goracy J; Peregud-Pogorzelska M; Goracy I; Kaczmarczyk M; Kornacewicz-Jach Z; Naruszewicz M; Ciechanowicz A
    Pol Arch Med Wewn; 2006 Feb; 115(2):105-11. PubMed ID: 17274465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes.
    Diet F; Graf C; Mahnke N; Wassmer G; Predel HG; Palma-Hohmann I; Rost R; Böhm M
    Eur J Clin Invest; 2001 Oct; 31(10):836-42. PubMed ID: 11737220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.
    Lindpaintner K; Lee M; Larson MG; Rao VS; Pfeffer MA; Ordovas JM; Schaefer EJ; Wilson AF; Wilson PW; Vasan RS; Myers RH; Levy D
    N Engl J Med; 1996 Apr; 334(16):1023-8. PubMed ID: 8598840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms.
    Fatini C; Abbate R; Pepe G; Battaglini B; Gensini F; Ruggiano G; Gensini GF; Guazzelli R
    Eur Heart J; 2000 Apr; 21(8):633-8. PubMed ID: 10731400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction.
    Steeds RP; Wardle A; Smith PD; Martin D; Channer KS; Samani NJ
    Atherosclerosis; 2001 Jan; 154(1):123-8. PubMed ID: 11137090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specifics of distribution of polymorphic markers of the renin-angiotensin-system genes, relation to ventricular hypertrophy in patients with essential hypertension of Uzbek nationality].
    Khamidullaeva GA; Eliseeva MR; Srozhiddinova NZ; Abdullaeva GZh
    Kardiologiia; 2007; 47(4):54-8. PubMed ID: 18260840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.
    Celentano A; Mancini FP; Crivaro M; Palmieri V; Ferrara LA; De Stefano V; Di Minno G; de Simone G
    Am J Cardiol; 1999 Apr; 83(8):1196-200. PubMed ID: 10215283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes.
    Karjalainen J; Kujala UM; Stolt A; Mäntysaari M; Viitasalo M; Kainulainen K; Kontula K
    J Am Coll Cardiol; 1999 Aug; 34(2):494-9. PubMed ID: 10440164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.
    Tanriverdi H; Evrengul H; Mergen H; Acar C; Seleci D; Kuru O; Tanriverdi S; Kaftan A
    Heart Vessels; 2007 Jan; 22(1):1-8. PubMed ID: 17285438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.
    Di Mauro M; Izzicupo P; Santarelli F; Falone S; Pennelli A; Amicarelli F; Calafiore AM; Di Baldassarre A; Gallina S
    Med Sci Sports Exerc; 2010 May; 42(5):915-21. PubMed ID: 19997001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease.
    Rice GI; Foy CA; Grant PJ
    Cardiovasc Res; 1999 Mar; 41(3):746-53. PubMed ID: 10435047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
    Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
    Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.
    Kasikcioglu E; Kayserilioglu A; Ciloglu F; Akhan H; Oflaz H; Yildiz S; Peker I
    Heart Vessels; 2004 Nov; 19(6):287-93. PubMed ID: 15799176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.